PLAG1 and cancer: The correlation analysis between PLAG1 and drug sensitivity demonstrates that, within the cancer therapeutics response portal (CTRP) and genomics of drug sensitivity in cancer (GDSC) databases, PLAG1 expression is significantly correlated with the sensitivity to various anticancer drugs, including pluripotin, tubastatin A, PIK-93, and AT-7519 (Figures 7C, D).